Axena Health is a women-led startup focused on improving the lives of women suffering from pelvic floor disorders. Their flagship product, the Leva Pelvic Health System, is a prescription digital therapeutic designed for at-home treatment of urinary incontinence and chronic fecal incontinence. The company's commitment to enhancing women's pelvic health has garnered significant attention, as evidenced by their recent $9.40M Series A investment on April 4, 2024. The notable investors in this round include Avestria Ventures, Cross-Border Impact Ventures, KOFA Healthcare Investments, and AXA Investment Managers. Axena Health operates within the Health Care and Medical Devices industries, providing innovative digital solutions for pelvic health and incontinence treatment. With a compelling mission and strong financial backing, Axena Health is poised to make a meaningful impact in this crucial area of women's healthcare.
No recent news or press coverage available for Axena Health.